全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Bronchial and Nonbronchial Systemic Artery Embolization in Management of Hemoptysis: Experience with 348 Patients

DOI: 10.1155/2013/263259

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background. We aimed to report our experience with bronchial artery embolization (BAE) in the management of moderate recurrent and/or life-threatening hemoptysis. Methods. We evaluated the demographics, clinical presentation, radiographic studies, short- and long-term efficacy, and complications in patients Who underwent BAE, at a tertiary university hospital, from 2003 to 2012. Results. Three hundred forty-one patients underwent BAE for the management of moderate recurrent or life-threatening hemoptysis. Pulmonary TB and bronchiectasis were the most common etiologies for hemoptysis in our locality. The most common angiographic signs for hemoptysis were hypervascularity and systemic-pulmonary artery shunt. BAE was successful in controlling hemoptysis immediately in 95% of patients and at 1 month in 90% of patients. Recurrence of hemoptysis was observed in 9.6% of patients, and reembolization was indicated in 85% of those cases. Complications of BAE were self-limited acute and subacute complications, while chronic complications were not recorded during this study. Conclusions. TB and bronchiectasis are the commonest etiologies for moderate recurrent or life-threatening hemoptysis in our locality. Hypervascular lesions from the bronchial arteries and nonbronchial systemic arteries represented the major vascular abnormalities. Bronchial and nonbronchial systemic artery embolizations were effective to control both acute and chronic hemoptyses, with no serious complications. 1. Introduction Hemoptysis, when massive and untreated, has a mortality rate of >50% [1]. In the majority of cases, the source of massive hemoptysis is the bronchial circulation. However, nonbronchial systemic arteries can be also a significant source [2]. Bronchial artery embolization (BAE) involves selective bronchial artery catheterization and angiography, followed by embolization of any identified abnormal vessels to stop the bleeding. It is a safe and effective nonsurgical therapeutic option for patients with massive hemoptysis. Nonbronchial systemic arteries, however, can be a significant source of massive hemoptysis and a cause of recurrence after successful BAE. Chronic recurrent hemoptysis can occur in chronic lung disorders such as bronchiectasis and tuberculosis in which hemoptysis is troublesome though not immediately lifethreatening [3]. Recent studies [3–5] have confirmed the effectiveness of BAE in the management of moderate (more than or equal to three episodes of 100?mL of bleeding per day within 1 week) and even mild (chronic or slowly increasing) hemoptysis cases.

References

[1]  E. Jean-Baptiste, “Clinical assessment and management of massive hemoptysis,” Critical Care Medicine, vol. 28, no. 5, pp. 1642–1647, 2000.
[2]  W. Yoon, J. K. Kim, Y. H. Kim, T. W. Chung, and H. K. Kang, “Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review,” Radiographics, vol. 22, no. 6, pp. 1395–1409, 2002.
[3]  S. Lee, J. W. Chan, S. C. Chan et al., “Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemoptysis,” Hong Kong Medical Journal, vol. 14, no. 1, pp. 14–20, 2008.
[4]  A. Poyanli, B. Acunas, I. Rozanes et al., “Endovascular therapy in the management of moderate and massive haemoptysis,” British Journal of Radiology, vol. 80, no. 953, pp. 331–336, 2007.
[5]  M. Antonelli, F. Midulla, G. Tancredi et al., “Bronchial artery embolization for the management of nonmassive hemoptysis in cystic fibrosis,” Chest, vol. 121, no. 3, pp. 796–801, 2002.
[6]  K. L. Swanson, C. M. Johnson, U. B. Prakash, M. A. McKusick, J. C. Andrews, and A. W. Stanson, “Bronchial artery embolization: experience with 54 patients,” Chest, vol. 121, no. 3, pp. 789–795, 2002.
[7]  H. Mal, I. Rullon, F. Mellot et al., “Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis,” Chest, vol. 115, no. 4, pp. 996–1001, 1999.
[8]  E. Serasli, V. Kalpakidis, K. Iatrou, V. Tsara, D. Siopi, and P. Christaki, “Percutaneous bronchial artery embolization in the management of massive hemoptysis in chronic lung diseases: immediate and long-term outcomes,” International Angiology, vol. 27, no. 4, pp. 319–328, 2008.
[9]  R. K. Chawla, A. Madan, D. Mehta, and K. Chawla, “Controlling hemoptysis: an alternative approach,” Lung India, vol. 27, no. 2, pp. 99–101, 2010.
[10]  J. Remy, C. Voisin, M. Ribet et al., “Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization,” La Nouvelle Presse Medicale, vol. 2, no. 31, pp. 2060–2068, 1973.
[11]  J. F. Stoll and M. A. Bettmann, “Bronchial artery embolization to control hemoptysis: a review,” CardioVascular and Interventional Radiology, vol. 11, no. 5, pp. 263–269, 1988.
[12]  V. L. Chan, L. K. So, J. Y. Lam et al., “Major haemoptysis in Hong Kong: aetiologies, angiographic findings and outcomes of bronchial artery embolisation,” International Journal of Tuberculosis and Lung Disease, vol. 3, no. 9, pp. 1167–1173, 2009.
[13]  B. Hirshberg, I. Biran, M. Glazer, and M. R. Kramer, “Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital,” Chest, vol. 112, no. 2, pp. 440–444, 1997.
[14]  A. M. Gross, A. H. Diacon, M. M. van den Heuvel, J. van Rensburg, D. Harris, and C. T. Bolliger, “Management of life-threatening haemoptysis in an area of high tuberculosis incidence,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 12, pp. 875–880, 2009.
[15]  B. S. Shin, G. S. Jeon, S. A. Lee, and M.-H. Park, “Bronchial artery embolisation for the management of haemoptysis in patients with pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 15, no. 8, pp. 1093–1098, 2011.
[16]  U. B. S. Prakash, “Bronchial artery embolization for massive hemoptysis,” Journal of Bronchology, vol. 10, no. 1, pp. 3–6, 2003.
[17]  A. E. Y?ld?z, O. M. Ar?yürek, E. Akp?nar, B. Peynircio?lu, and B. E. ?il, “Multidetector CT of bronchial and non-bronchial systemic arteries,” Diagnostic and Interventional Radiology, vol. 17, pp. 10–17, 2011.
[18]  H. Mori, Y. Ohno, Y. Tsuge et al., “Use of multidetector row CT to evaluate the need for bronchial arterial embolization in hemoptysis patients,” Respiration, vol. 80, no. 1, pp. 24–31, 2010.
[19]  S. Hahn, Y. J. Kim, W. Kwon, S. W. Cha, and W. Y. Lee, “Comparison of the effectiveness of embolic agents for bronchial artery embolization: gelfoam versus polyvinyl alcohol,” Korean Journal of Radiology, vol. 11, no. 5, pp. 542–546, 2010.
[20]  A. Khalil, M. Fartoukh, M. Bazot, A. Parrot, C. Marsault, and M. F. Carette, “Systemic arterial embolization in patients with hemoptysis: initial experience with ethylene vinyl alcohol copolymer in 15 cases,” American Journal of Roentgenology, vol. 194, no. 1, pp. W104–W110, 2010.
[21]  S. Saluja, K. J. Henderson, and R. White, “Embolotherapy in the bronchial and pulmonary circulations,” Radiologic Clinics of North America, vol. 38, no. 2, pp. 425–448, 2000.
[22]  J.-Y. Chun, R. Morgan, and A.-M. Belli, “Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization,” CardioVascular and Interventional Radiology, vol. 33, no. 2, pp. 240–250, 2010.
[23]  B. Ghaye and R. F. Dondelinger, “Imaging guided thoracic interventions,” European Respiratory Journal, vol. 17, no. 3, pp. 507–528, 2001.
[24]  G. M. Brinson, P. G. Noone, M. A. Mauro et al., “Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1951–1958, 1998.
[25]  C. Witt, B. Schmidt, A. Geisler et al., “Value of bronchial artery embolisation with platinum coils in tumorous pulmonary bleeding,” European Journal of Cancer, vol. 36, no. 15, pp. 1949–1954, 2000.
[26]  Y. Matsuo, T. Okada, M. Yamaguchi, et al., “Coil embolization of bronchial artery aneurysm with high flow bronchial artery-pulmonary artery fistula,” World Journal of Cardiovascular Diseases, vol. 3, pp. 14–17, 2013.
[27]  B. üstüns?z, U. Bozlar, F. ?rs, S. Gürk?k, A. Balkan, and T. Il?ca, “Bronchial artery embolization: experience with 10 cases,” Diagnostic and Interventional Radiology, vol. 12, pp. 43–46, 2006.
[28]  M. M. Slattery, A. N. Keeling, and M. J. Lee, “Outcome and complications of bronchial artery embolisation for life-threatening haemoptysis,” Irish Journal of Medical Science, vol. 178, no. 2, pp. 155–159, 2009.
[29]  N. Tanaka, K. Yamakado, S. Murashima et al., “Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system,” Journal of Vascular and Interventional Radiology, vol. 8, no. 1, pp. 65–70, 1997.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133